How to Safely Taper Off Baclofen and Manage Withdrawal

Baclofen should never be stopped suddenly. Whether you take it by mouth for muscle spasticity or receive it through an implanted pump, abruptly discontinuing this medication can trigger a withdrawal syndrome that ranges from uncomfortable to life-threatening. A safe taper involves gradually reducing your dose over weeks, under the guidance of a prescriber who can adjust the pace based on how you respond. The process sounds straightforward, but it has real pitfalls that are worth understanding before you begin.

Why Stopping Suddenly Is Dangerous

Baclofen works by calming overactive nerve signaling in the brain and spinal cord. When you take it regularly, your nervous system adjusts to its presence and begins to rely on it to maintain a certain baseline of inhibitory activity. Remove the drug too quickly, and that baseline disappears. The nervous system, no longer held in check, can rebound into a state of dangerous overexcitement.

This rebound can produce withdrawal symptoms within hours to days of the last dose, depending on how much baclofen you were taking and how it was being delivered. A narrative review of baclofen’s complications described the withdrawal syndrome as potentially life-threatening, requiring prompt recognition and a high degree of clinical suspicion to catch early.1PubMed Central. Baclofen therapeutics, toxicity, and withdrawal: A narrative review In one published case, a 62-year-old woman whose oral baclofen was simply not restarted after a hospital transfer developed altered mental status and respiratory failure severe enough to land her in the intensive care unit.2PubMed Central. Oral Baclofen Withdrawal Resulting in Progressive Weakness and Sedation Requiring Intensive Care Admission These are not fringe scenarios. They happen when a prescription falls through the cracks during a hospital stay, when a pharmacy runs out, or when a patient decides to quit on their own.

Recognizing Withdrawal Symptoms

Baclofen withdrawal can look very different from person to person, and the symptoms sometimes mimic other conditions, which makes it easy to miss. The most commonly reported signs include:

  • Increased spasticity: A return and often worsening of the muscle tightness baclofen was controlling in the first place.
  • Sedation and weakness: Paradoxically, some people become excessively drowsy or weak, rather than agitated, especially in the early stages.2PubMed Central. Oral Baclofen Withdrawal Resulting in Progressive Weakness and Sedation Requiring Intensive Care Admission
  • Fever and rapid heart rate: The autonomic nervous system can become unstable, producing high temperatures, sweating, and a racing pulse.
  • Psychological symptoms: Confusion, agitation, hallucinations, and anxiety have all been documented.
  • Seizures: In severe cases, withdrawal can provoke seizures that are difficult to control.

At the extreme end, withdrawal has been associated with rhabdomyolysis, a dangerous breakdown of muscle tissue, and disseminated intravascular coagulation, a clotting disorder.3The Journal of Emergency Medicine. Intrathecal baclofen withdrawal mimicking sepsis These severe complications are more common with intrathecal (pump-delivered) baclofen, but they have been reported with oral use as well. The key takeaway is that withdrawal is not simply a return to your pre-treatment state. It can produce symptoms you never had before, and some of them require emergency care.

How an Oral Taper Typically Works

There is no single taper schedule that fits everyone. The general principle is to reduce your dose in small steps, holding at each new dose long enough to confirm you are tolerating it before stepping down again. Many prescribers reduce the total daily dose by about 5 to 10 milligrams every few days to a week, though the pace depends on how much you have been taking, how long you have been on the drug, and how sensitive you are to changes.

If you are on a relatively low dose, say 30 milligrams a day split into three doses, the taper might take a couple of weeks. Someone on a high dose for years will need a much more gradual schedule, sometimes stretching over a month or more. Your doctor will typically ask you to report any uptick in spasticity, mood changes, or new symptoms at each step. If withdrawal signs appear, the standard approach is to go back up to the last tolerated dose and slow the taper from there.1PubMed Central. Baclofen therapeutics, toxicity, and withdrawal: A narrative review

A few practical points that tend to get overlooked:

  • Do not skip doses to speed things up. Baclofen has a relatively short duration of action. Skipping a dose creates a mini-withdrawal window that can trigger symptoms and make the whole process harder.
  • Keep a symptom log. Subtle early signs like increased muscle stiffness, trouble sleeping, or mild anxiety are your cue that the taper may be moving too fast. Catching these early means you can pause or slow down before symptoms escalate.
  • Plan for pharmacy logistics. If your taper requires half-tablets or doses that do not match standard pill sizes, make sure you and your pharmacist sort that out in advance. Running out of the right dose mid-taper is a common and preventable problem.

Intrathecal Baclofen Pumps and Their Unique Risks

People who receive baclofen through an implanted pump face a different and in some ways more dangerous withdrawal scenario. The intrathecal route delivers tiny amounts of the drug directly into the spinal fluid, which means the brain becomes accustomed to a very concentrated local supply. Withdrawal from intrathecal baclofen tends to be more severe and develops faster than withdrawal from oral baclofen.1PubMed Central. Baclofen therapeutics, toxicity, and withdrawal: A narrative review

The most common triggers are not intentional dose reductions but mechanical problems: a kinked or disconnected catheter, a pump battery running down, or a refill appointment that gets missed. One review of unusual pump failures emphasized that worsening spasticity should be treated as a warning sign, and that every level of the pump and catheter system needs to be checked step by step when withdrawal is suspected.4PubMed Central. Unusual mechanical failures of intrathecal baclofen pump systems: symptoms, signs, and trouble shooting In many published cases, the episodes were caused by preventable human errors or pump malfunctions rather than deliberate tapering.5PubMed Central. Intrathecal baclofen withdrawal syndrome- a life-threatening complication of baclofen pump: a case report

An important clinical finding is that simply switching to oral baclofen does not reliably prevent or treat intrathecal withdrawal. The doses used in intrathecal therapy are a fraction of an oral dose, but they reach the spinal cord directly, so the effective concentration at the target site is much higher than oral baclofen can replicate. Case reports have shown that oral replacement alone often fails to control symptoms in this setting.5PubMed Central. Intrathecal baclofen withdrawal syndrome- a life-threatening complication of baclofen pump: a case report The priority in acute intrathecal withdrawal is restoring the intrathecal drug delivery as quickly as possible, with intensive care support and sedating medications used as a bridge.

What Doctors Use When Withdrawal Gets Severe

When withdrawal symptoms escalate despite attempts to reinstate baclofen, clinicians turn to a handful of adjunctive medications. The goal is to calm the runaway nervous system activity while the underlying baclofen delivery problem is being fixed or the dose is being re-established. The options include benzodiazepines, propofol, dantrolene, dexmedetomidine, tizanidine, and cyproheptadine.6Receptors. Baclofen Safety, Toxicity, Withdrawal, and Overdose

Benzodiazepines are typically the first-line add-on because they enhance inhibitory signaling through a related but distinct pathway. In intrathecal withdrawal emergencies, high doses are sometimes needed, and propofol infusion in an ICU setting has been used to manage cases where benzodiazepines alone fall short.7Spinal Cord. Management of acute overdose or withdrawal state in intrathecal baclofen therapy

Cyproheptadine, a drug more commonly associated with treating allergies and stimulating appetite, has emerged as a surprisingly useful tool. In a case series, patients given cyproheptadine during intrathecal withdrawal showed significant drops in fever and heart rate, with heart rates falling from the 120-to-140 range down to under 100 beats per minute. Reflexes, muscle tone, and involuntary jerking also improved, and patients reported dramatic relief from itching, a symptom that can be intense during withdrawal.8PubMed. Cyproheptadine for intrathecal baclofen withdrawal The drug has also been used successfully in pediatric cases.9PubMed. Cyproheptadine for pediatric intrathecal baclofen withdrawal: a case report More recently, a case report described using high-dose dantrolene and cyproheptadine together as salvage therapy for severe intrathecal baclofen withdrawal, with good tolerability and symptom improvement.10PubMed. Dantrolene and cyproheptadine as salvage therapy for severe intrathecal baclofen withdrawal: A case report

These medications are tools for emergencies, not for routine tapering. If your outpatient taper is going smoothly, you should not need any of them. Their relevance is mainly for people in hospital settings whose withdrawal has reached a crisis point.

Kidney Disease Makes Everything Harder

Baclofen is primarily cleared by the kidneys, with roughly 70 to 85 percent of the drug excreted in urine.11PubMed. Baclofen Toxicity in a Patient with Hemodialysis-Dependent End-Stage Renal Disease If your kidneys are not working well, the drug hangs around longer, and its half-life is prolonged.12PubMed Central. Baclofen-induced myoclonus in patients with renal impairment: A case series This matters for tapering in two ways.

First, people with chronic kidney disease may have been accumulating the drug to higher-than-expected levels even at standard doses, meaning their withdrawal risk during a taper is elevated. Some patients with impaired kidney function have developed toxicity symptoms within hours of a single tablet.13PubMed Central. Baclofen-induced neurotoxicity in chronic kidney disease: Is there a safe dose? Second, because the drug clears more slowly, dose reductions may need to be even smaller and spaced further apart to avoid a sudden effective drop in drug levels. If you have any degree of kidney impairment, your prescriber should factor that into your taper schedule. Hemodialysis can remove baclofen from the blood, which is relevant in overdose situations but also means that dialysis sessions could inadvertently accelerate withdrawal if not accounted for.

When Baclofen Withdrawal Gets Mistaken for Something Else

One of the trickier aspects of baclofen withdrawal is that it can masquerade as other conditions. The combination of fever, fast heart rate, and confusion looks a lot like sepsis, and published cases describe patients being treated with antibiotics and fluid resuscitation for presumed infection while the real problem was unrecognized baclofen withdrawal.3The Journal of Emergency Medicine. Intrathecal baclofen withdrawal mimicking sepsis In the intrathecal pump population, this is a well-documented pitfall.

A related diagnostic trap occurs in people who take baclofen for alcohol use disorder. A case report described three patients on chronic baclofen therapy for alcohol problems who showed up in emergency settings with confusion that was initially diagnosed as alcohol withdrawal. They were treated with benzodiazepines, which helped only marginally. Retrospective analysis determined that all three were actually experiencing baclofen withdrawal, not alcohol withdrawal.14PubMed. Assessing alcohol versus baclofen withdrawal syndrome in patients treated with baclofen for alcohol use disorder The distinction matters because the treatment is different: baclofen withdrawal is best addressed by restarting baclofen, whereas alcohol withdrawal is typically managed with benzodiazepines alone. If you are taking baclofen for alcohol-related reasons and end up in an emergency room, make sure the team knows about the baclofen. It can easily be overlooked when alcohol is part of the clinical picture.

Neonatal Withdrawal After In-Utero Exposure

Baclofen crosses the placenta, which means newborns whose mothers took the drug during pregnancy can experience withdrawal after birth. This scenario is uncommon but is being recognized more often as clinicians become aware of it. In one case, a male infant born at about 34 weeks to a mother who had been taking 30 milligrams of oral baclofen four times daily showed extensor posturing within 15 minutes of delivery. The medical team started the newborn on a baclofen taper beginning within hours of birth, monitoring withdrawal using a standardized scoring tool. The infant tolerated the taper and was successfully off baclofen by the fourteenth day of life with no apparent neurological deficits.15PubMed. Neonatal baclofen withdrawal following intrauterine exposure

The broader message from case reports in this area is that neonates exposed to baclofen in utero require close monitoring and a plan for possible postnatal treatment. The starting dose, taper schedule, and observation period need to be tailored to the mother’s dose and the newborn’s kidney function.16Pediatric Dimensions. Baclofen withdrawal in a neonate If you are pregnant and taking baclofen, this is a conversation to have with your obstetrician and the neonatal team well before delivery. The possibility of neonatal withdrawal may not be on their radar unless you bring it up.17PM&R. Neonatal Baclofen Withdrawal Following Intrauterine Exposure: A Case Report

Protecting Yourself During the Process

Most of the horror stories in the medical literature involve unintentional abrupt cessation rather than poorly executed tapers. That means the biggest risk factor is not the taper itself but the situations that interrupt your access to the drug. Hospital admissions are a common culprit: your home medications may not be continued if the admitting team is focused on a different problem and does not recognize baclofen as a drug that requires uninterrupted dosing. Skilled nursing facilities, as in the case described earlier, have also been responsible for lapses.

If you are heading into any kind of hospitalization or facility-based care, make sure baclofen is on your medication list and that the clinical team understands it cannot be stopped abruptly. Wearing a medical alert bracelet or carrying a card that lists baclofen among your critical medications is worth considering, especially if you have a pump. For intrathecal pump users, knowing your refill schedule and having a plan for who to contact if the pump alarms or you notice a sudden increase in spasticity can be the difference between a routine fix and an ICU admission.

People sometimes want to stop baclofen because of side effects like drowsiness, dizziness, or cognitive fog. Those are legitimate reasons, but the solution is always a gradual taper, never cold turkey. Even if the side effects feel worse than the spasticity, resist the urge to just stop taking it. Talk to your prescriber, set up a taper schedule, and proceed carefully. The withdrawal risk is real, it is well documented, and it is almost entirely avoidable with a little planning.

Pooja Rao

As a Board Certified Geriatric Pharmacist, Pooja Rao has 14 years of practice in long-term care and home health. She earned her PharmD at the University of Florida. Her specialty is medication management in older adults, particularly deprescribing and drugs that raise fall risk.